igf-1 lr3 / des Recombinant Human IGF-I/IGF-1 GMP Protein, CF IGF-1 LR3 1MG

Administering 75 mg/kg/day of FA to high-fat-fed LDL receptor-deficient (LDLR/) mice for 16 weeks resulted in a significant inhibition in atherosclerosis plaque progression and vascular smooth muscle cell (VSMC) dedifferentiation by modulating the mTOR/p70S6K signaling pathway, which involved the reduction in lipid levels and the suppression of oxidative stress and inflammatory response [82]

Although some resulted in a positive metabolic effect induced by the intervention, no beneficial clinical effect was detected [80, 89]

Cell Stem Cell (2014) 14(3):32941

In vivo corneal permeability study Coumarin-6 was used as a fluorescent surrogate for latanoprost to simulate the corneal permeation process